Literature DB >> 2583209

PET and MR imaging in a neuro-Behçet syndrome.

K Wildhagen1, G J Meyer, G Stoppe, P Heintz, H Deicher, H Hundeshagen.   

Abstract

Positron emission tomography (PET) and magnetic resonance imaging (MRI) studies were performed on a case of neuro-Behçet's syndrome. In accordance with the clinical signs, FDG PET (using 18F-labeled 2-F-2'-desoxyglucose) revealed disseminated storage defects in the cerebrum and cerebellum. Focal regions of enhanced signal intensity were demonstrated in the parietal white matter of the cerebrum in T2-weighted images and in the brain stem by MRI.

Entities:  

Mesh:

Year:  1989        PMID: 2583209     DOI: 10.1007/bf00631773

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  12 in total

1.  INVOLVEMENT OF NERVOUS SYSTEM IN BEHCET'S SYNDROME.

Authors:  S M WOLF; D L SCHOTLAND; L L PHILLIPS
Journal:  Arch Neurol       Date:  1965-03

2.  Behcet syndrome presenting as cerebrovascular disease.

Authors:  V J Iragui; E Maravi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-07       Impact factor: 10.154

3.  Neuro-Behçet's disease with alternating hemiparesis.

Authors:  Y Kuroiwa; H Tohgi; H Kanayama; M Fujimori; H Aoki
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

Review 4.  Positron emission tomography and its application to the study of cerebrovascular disease in man.

Authors:  W J Powers; M E Raichle
Journal:  Stroke       Date:  1985 May-Jun       Impact factor: 7.914

5.  CT and MR imaging in neuro-Behçet disease.

Authors:  J Willeit; E Schmutzhard; F Aichner; U Mayr; F Weber; F Gerstenbrand
Journal:  J Comput Assist Tomogr       Date:  1986 Mar-Apr       Impact factor: 1.826

6.  Pathologic features of Behçet's syndrome: a review of Japanese autopsy registry data.

Authors:  S Lakhanpal; K Tani; J T Lie; K Katoh; Y Ishigatsubo; T Ohokubo
Journal:  Hum Pathol       Date:  1985-08       Impact factor: 3.466

7.  The relationship of HLA-B and DR phenotypes to Behcet's syndrome, recurrent oral ulceration and the class of immune complexes.

Authors:  T Lehner; K I Welsh; J R Batchelor
Journal:  Immunology       Date:  1982-12       Impact factor: 7.397

Review 8.  Behçet disease (Behçet syndrome).

Authors:  T Shimizu; G E Ehrlich; G Inaba; K Hayashi
Journal:  Semin Arthritis Rheum       Date:  1979-05       Impact factor: 5.532

9.  Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome.

Authors:  H Yazici; Y Tüzün; H Pazarli; S Yurdakul; Y Ozyazgan; H Ozdoğan; S Serdaroğlu; M Ersanli; B Y Ulkü; A U Müftüoğlu
Journal:  Ann Rheum Dis       Date:  1984-12       Impact factor: 19.103

10.  Magnetic resonance images of neuro-Behçet syndrome show precise brain stem lesions. Report of a case.

Authors:  H Fukuyama; M Kameyama; H Nabatame; M Takemura; K Nishimura; I Fujisawa; K Torizuka
Journal:  Acta Neurol Scand       Date:  1987-01       Impact factor: 3.209

View more
  5 in total

1.  18FDG imaging of giant cell arteritis: usefulness of whole-body plus brain PET.

Authors:  Tarik Belhocine
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-29       Impact factor: 9.236

2.  A plea for the elective inclusion of the brain in routine whole-body FDG PET.

Authors:  Tarik Belhocine; Stefan Markus Weiner; Ingo Brink; Peter Paul De Deyn; Jan Roland; Thierry Van der Borght; Patrick Flamen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03       Impact factor: 9.236

Review 3.  Clinical utility of FDG-PET and PET/CT in non-malignant thoracic disorders.

Authors:  Sandip Basu; Babak Saboury; Tom Werner; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2011-12       Impact factor: 3.488

4.  Sequential gadolinium-DTPA enhanced MRI studies in neuro-Behçet's disease.

Authors:  S Kazui; H Naritomi; S Imakita; N Yamada; M Ogawa; T Sawada
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

5.  rCBF abnormalities detected, and sequentially followed, by SPECT in neuro-Behçet's syndrome with normal CT and MRI imaging.

Authors:  H S Markus; C B Bunker; K Kouris; D C Costa; M J Harrison
Journal:  J Neurol       Date:  1992-08       Impact factor: 4.849

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.